Disir
Platinum Member
- Sep 30, 2011
- 28,003
- 9,607
- 910
In the first clinical trial of its kind, researchers used the gene-editing tool CRISPR to fine-tune the DNA of people's immune cells, in hopes of fighting cancer.
Now, preliminary data from the trial suggest that this technique is safe for use in cancer patients.
gene editing of these cells," study co-author Dr. Edward Stadtmauer, a professor of oncology at the University of Pennsylvania, told the Associated Press.
Still, "this treatment is not ready for prime time," Stadtmauer added in an interview with NPR. "But it is definitely very promising."
Doctors Are Trying to Use CRISPR to Fight Cancer. The 1st Trial Suggests It's Safe. | Live Science
They need to hurry up with this treatment.
Now, preliminary data from the trial suggest that this technique is safe for use in cancer patients.
gene editing of these cells," study co-author Dr. Edward Stadtmauer, a professor of oncology at the University of Pennsylvania, told the Associated Press.
Still, "this treatment is not ready for prime time," Stadtmauer added in an interview with NPR. "But it is definitely very promising."
Doctors Are Trying to Use CRISPR to Fight Cancer. The 1st Trial Suggests It's Safe. | Live Science
They need to hurry up with this treatment.